Cutting-Edge Health Research at IMMCA: Advancements in Neurodegenerative Disease Diagnosis and Treatment

2023-08-24 19:26:00

The holder of the health portfolio, Luis Medina Ruiztoured the IMMCA facilities and said that Tucumans should be proud to have an institution like that.

“They work with high technology and are committed to society. Everything they investigate is applied for the benefit of patients. They do so with issues related to neurodegenerative diseases and carry out pioneering research in the world. There is no better technology than what is in this institute. I want to thank and congratulate Dr. Roxana Chehin and Dr. Diego Ploper, professionals who make our province proud,” said Medina Ruiz.

For her part, the director of the IMMCA (Institute of Applied Molecular and Cellular Medicine), Dr. Roxana ChehinHe commented that they are a cutting-edge experiment, since they put scientists within public health. “We have been working together at Siprosa for five years, offering them our contribution with all the pre-installed capabilities we have. And we contribute to certain demands that the system may have, as in the case of the pandemic or dengue, especially in the diagnosis, ”he added.

Finally, the doctor Diego Plopper, Conicet associate researcher, works at the IMMCA and said that they are mainly dedicated to neurodegenerative diseases, seeking both diagnostic and therapeutic methods. “During the pandemic, for example, we worked to get a diagnostic test that was used here in the province. Then, we went back to study neurodegenerative diseases and we are studying new drugs that could serve as a treatment for these diseases ”, he closed.

1692906995
#work #Institute #Applied #Molecular #Cellular #Medicine #stands

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.